E/M Coding Alert - 2013 Issue 40
Medicare Drug Screens: G0431, G0434 Define Your Options
Subscribe or sign in to view the full article.
Article Overview
This article covers Medicare billing guidance for drug screening tests and explains why standard CPT drug screen codes are not used for this payer. It introduces the HCPCS Level II options discussed in the article, the role of CLIA complexity classification, and related Medicare compliance topics such as units, bundling edits, and modifier usage. The content is aimed at coders, billers, laboratory staff, and compliance professionals who work with Medicare laboratory claims.
Why This Topic Matters
Medicare drug screening claims follow a different framework than standard CPT reporting, so understanding the applicable HCPCS Level II structure and associated compliance considerations helps reduce claim errors and denials.
Article Sections
-
Drug screening codes for Medicare
Introduces the Medicare-specific reporting framework for drug screening tests and contrasts it with standard CPT-based reporting.
-
Know CLIA Certification
Summarizes how CLIA complexity categories relate to selection of the appropriate HCPCS Level II drug screening code.
-
Beware of These Compliance Issues
Covers general Medicare claim compliance topics tied to drug screening, including units, bundling edits, and modifier use.
What You Will Learn
- How Medicare drug screening reporting differs from standard CPT-based reporting
- How CLIA complexity categories relate to Medicare drug screening code selection
- What general compliance issues are associated with Medicare drug screen claims
- Which organizations and guidance sources are referenced in the discussion
Who Should Read This
- Medical coders
- Billing staff
- Laboratory personnel
- Compliance professionals
- Revenue cycle teams
Codes Discussed
Modifiers Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com